Skip to content

Optimal intake dose setting test of Basidiomycetes-X

Optimal intake dose setting test of Basidiomycetes-X - Optimal intake dose setting test of Basidiomycetes-X

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000033706
Enrollment
100
Registered
2018-08-10
Start date
2018-08-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer

Interventions

Take a test food (low dose) (12 weeks) Take a test food (medium dose) (12 weeks) Take the test food (high dose) (12 weeks) Take the control food (12 weeks)

Sponsors

Mycology Techno CORP.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: [1]Japanese males and females aged 40-65 years [2]Individuals who are healthy and are not received treatment of disease [3]Individuals whose BMI is 23 to 30kg/m2 [4]Individuals whose written informed consent has been obtained [5]Individuals who can come to the designated examination date and receive the examination [6]Individuals judged appropriate for the study by the principal

Exclusion criteria

Exclusion criteria: [1]Individuals using medical products [2]Individuals under treatment or with history of mental disorders, sleep disorders, hypertension, diabetes, lipid metabolism abnormality, or other serious disorders [3]Individuals receiving/received medical drug treatment for the past 1 month except for temporary relief medication for headache, menstrual pain, common cold, etc. [4]Individuals with history of serious diseases (hepatic, renal, cardiovascular, respiratory, hematologic, etc.) [5]Individuals with history of gastrointestinal disorders except for appendicitis [6]Individuals who donated blood over 200mL in the past 1 month or over 400mL in the past 3 months [7]Individuals who have experienced mood disorder or condition deterioration due to blood sampling in the past [8]Individuals with serious anemia [9]Individuals deemed sensitive to the test product or highly allergic to foods or medical drugs [10]Individuals who excessively take alcohol (expressed in an amount of alcohol: over 40mg/day) [11]Individuals whose number of smokers exceeds 20 on average per day [12]Individuals whose life style will change during the test period (ex. travel for a long time) [13]Individuals who are pregnant or are posslibly, or are lactating [14]Individuals who participated in other clinical studies in the past three months [15]Individual with potential conflict of interest [16]Individuals judged inappropriate for the study by the principal

Design outcomes

Primary

MeasureTime frame
ChE(6W,12W), TG(6W,12W)

Secondary

MeasureTime frame
AST,ALT,Gamma-GT,ALP,LDH,T-cho,LDL-cho,HDL-cho(6W,12W)

Countries

Japan

Contacts

Public ContactTatsuya Honda

DRC Co.,Ltd. Product Testing & Studies Division

honda@drc-web.co.jp06-6882-1130

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026